API tools faq
paste
Advertisement
Neha420

Heparin Market Size, Share, Growth, Industry Analysis by Trends and Forecast Report 2027

Neha420
Jul 29th, 2021
226
0
Never
Add comment
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 6.26 KB | None | 0 0
raw download clone embed print report
  1. The global heparin market size is expected to reach USD 11.43 billion by 2027, exhibiting a CAGR of 3.9% during the forecast period. The increasing cases of cardiovascular diseases such as deep vein thrombosis & pulmonary embolism are expected to spur demand for heparin in the forthcoming years, states Fortune Business Insights, in a report, titled “Heparin Market Size, Share & Industry Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source (Bovine, and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion, and Subcutaneous Injection), By End User (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 8.39 billion in 2019.
  2.  
  3. The report on the heparin market reveals:
  4.  
  5. Prominent insights into the industry
  6. Noteworthy data about major companies
  7. Emerging trends and drivers
  8. Comprehensive analysis of the segments
  9. COVID-19 effect on the industry
  10. For more information visit : https://www.fortunebusinessinsights.com/heparin-market-104447
  11.  
  12. Minimal Impact on the Market During COVID-19
  13.  
  14. The limitations on non-essential medical procedures and consultations has had a drastic impact on the global market amid COVID-19. The healthcare industry has observed a decline in other medical services besides coronavirus. The increased emphasis on COVID’s vaccine has reduced the demand for other therapeutics. Furthermore, the lack of supply and production of heparin will simultaneously limit the scope of the market. However, government initiatives, including heavy investments and free medical aid will influence the healthy growth of the market in the time of the pandemic.
  15.  
  16. High Adoption of Advanced Products to Boost Market in North America
  17.  
  18. The market size in North America stood at USD 4.28 billion in 2019. The growth in the region is attributed to the prevalence of cardiovascular diseases such as pulmonary embolism. The higher adoption of advanced heparin products will have an excellent effect on the market in the region. The increasing healthcare expenditure is expected to foster the healthy growth of the market in North America.
  19.  
  20. The presence of major companies can further enhance the development of the market in the region. Europe is expected to hold the largest share owing to the acceptance of technologically advanced products in the region. The rising number of patients suffering from a range of cardiovascular diseases will further spur opportunities in the region. Asia Pacific is expected to experience a rapid growth rate owing to the growing patient population. The surging healthcare expenditure in the developing nations will have a tremendous effect on the market in Asia Pacific.
  21.  
  22. Key Development:
  23.  
  24. May 2019: Pfizer, Inc. announced that it has received the approval from the U.S. FDA for the administration of its heparin product offering, Fragmin to minimize the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and above.
  25.  
  26. The Report Lists the Key Companies in the Heparin Market:
  27.  
  28. Opocrin S.p.A. (Formigine, Italy)
  29. Baxter (Deerfield, U.S.)
  30. Pfizer Inc. (New York, U.S.)
  31. Bioiberica S.A.U. (Barcelona, Spain)
  32. Fresenius SE & Co. KGaA (Bad Homburg, Germany)
  33. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China)
  34. B. Braun Melsungen AG (Melsungen, Germany)
  35. Dr. Reddy’s Laboratories Ltd. (Hyderabad, India)
  36. LEO Pharma A/S (Ballerup, Denmark)
  37. Aspen Holdings (Durban, South Africa)
  38. Other Players
  39. Global Heparin Market Segmentation :
  40.  
  41. By Product Type
  42.  
  43. UFH
  44. LMWH
  45. By Source
  46.  
  47. Bovine
  48. Porcine
  49. By Application
  50.  
  51. Deep Vein Thrombosis & Pulmonary Embolism
  52. Atrial Fibrillation
  53. Heart Attacks
  54. Stroke
  55. Others
  56. By Route of Administration
  57.  
  58. Intravenous Infusion
  59. Subcutaneous Injection
  60. By End-User
  61.  
  62. Hospitals & ASCs
  63. Clinics
  64. Others
  65. By Geography
  66.  
  67. North America
  68. By Product Type
  69. By Source
  70. By Application
  71. By Route of Administration
  72. By EndUser
  73. By Country
  74. Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/heparin-market-104447
  75.  
  76. SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
  77.  
  78. Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  79. Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  80. Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  81. Number of procedures and average price of procedures
  82. Replacement rate and pricing of capital equipment
  83. Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  84. Market & technological trends, new product developments, product pipeline.
  85. About Us:
  86.  
  87. Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
  88.  
  89. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
  90.  
  91. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
  92.  
  93. Contact Us:
  94.  
  95. Fortune Business Insights™ Pvt. Ltd.
  96. 308, Supreme Headquarters,
  97. Survey No. 36, Baner,
  98. Pune-Bangalore Highway,
  99. Pune - 411045, Maharashtra, India.
  100.  
  101. Phone:
  102. US :+1 424 253 0390
  103. UK : +44 2071 939123
  104. APAC : +91 744 740 1245
  105. Email: sales@fortunebusinessinsights.com
  106. Fortune Business Insights™
  107. LinkedIn | Twitter | Blogs
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement
Public Pastes
Advertisement
We use cookies for various purposes including analytics. By continuing to use Pastebin, you agree to our use of cookies as described in the Cookies Policy.  OK, I Understand
Not a member of Pastebin yet?
Sign Up, it unlocks many cool features!